Cash on hand provides over one year of runway to fund expected operations HOUSTON, TX / ACCESS Newswire / February 26, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a ...

Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments ...

Donna Adelson is appearing in court today with hopes of being released on bond pending trial for her alleged role in the planned murder of Dan Markel. The 75-year-old's attorneys, Josh Zelman a ...

CNS cancer is a type of cancer that forms in the central nervous system. It includes brain stem glioma, craniopharyngioma, medulloblastoma and meningioma. Stereotactic radiosurgery (SRS) has been ...

TALLAHASSEE, Fla. (WCTV) - Donna Adelson appeared before a judge Wednesday as she pushed to be released from jail while awaiting trial. After three hours in court, Circuit Judge Stephen Everett ...

The College of Natural Sciences Common Scholarship Application for current and continuing CNS students is now available through the Longhorn Awards & Student Scholarship Opportunities (LASSO) portal.

How many Broadway shows has Donna Murphy been in? Donna Murphy has appeared on Broadway in 11 shows. How many West End shows has Donna Murphy been in? Donna Murphy has not appeared in the West End.

O Ministério das Infraestruturas e Habitação anunciou no domingo a aprovação, em Conselho de Ministros, do novo modelo para atribuição do Subsídio Social de Mobilidade para as viagens regulares entre ...

Ed and Donna Kelce made history as the first parents with two sons playing against one another in the Super Bowl Emily Weaver is a contributing writer at PEOPLE. She has been working at PEOPLE ...

A circuit judge decided this week that Donna Adelson must stay in jail until her trial, which is scheduled for this summer. Circuit Judge Stephen Everett issued a ruling Monday that was unsealed ...

Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share agreement comes a few ...